Wellcome Trust awards Karuna Pharmaceuticals $8m

21-06-2018

Wellcome Trust awards Karuna Pharmaceuticals $8m

jansucko / iStockphoto.com

Biomedical research charity The Wellcome Trust has granted clinical-stage company Karuna Pharmaceuticals $8 million to further advance the clinical development of a schizophrenia treatment.


Wellcome Trust, Karuna Pharmaceuticals, schizophrenia, biomedical, KarXT, Andrew Miller, Lynsey Bilsland

LSIPR